Nicole L Lewis, MD
Family Practice · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 15 years
- Wayne State University School of Medicine, 2011
Offices
1 location · Sutter Valley Medical Foundation · 2,473 clinicians in this group
Hospitals listed: 557073 · Sutter Medical Center, Sacramento · Sutter Roseville Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Lewis’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence C159091 · Current
Licensed to practise in California · since 2018 · expires 2028-10-31 · Wayne State University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Family Medicine - Family Medicine
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sutter Medical Center, SacramentoSacramento, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.9 (12 to 15.9) · 992 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.066, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.335, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.215, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.46, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.253, Oct 2024 – Sep 2025
- Sutter Roseville Medical CenterRoseville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Pressure ulcer rate: 0.08 (0 to 0.56) · 12,400 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.069, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.262, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.128, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.357, Oct 2024 – Sep 2025
See every measure and the patient survey for Sutter Medical Center, Sacramento
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (12 to 15.9) · 992 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.066 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.335 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.215 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.46 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.253 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.12 (0.29 to 1.94) · 2,408 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.78 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.68 (126.66 to 206.71) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 292 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.8 · 543 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 425 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 441 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 5,216 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.11 (0 to 0.29) · 9,948 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.45) · 10,968 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.04 (1.53 to 4.56) · 3,983 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0.2 to 2.46) · 2,033 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.78 (1.69 to 3.87) · 3,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.79 (6.29 to 13.29) · 2,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.62 (4.04 to 9.2) · 2,018 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.29 to 2.98) · 867 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.54 (0.07 to 1.01) · 8,613 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 294 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 598 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 924 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 8.5 · 488 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18.3 · 638 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.4 · 443 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 600 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.9 to 6.1) · 992 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 298 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.3 (8.7 to 14.6) · 1,326 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 934 cases | No different | Jan 2024 – Dec 2024 |
What patients said (700 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Sutter Roseville Medical Center
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 5 better, 1 the same, 1 worse of 7 measures. Readmissions: 2 better, 7 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 0.08 (0 to 0.56) · 12,400 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.069 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.262 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.128 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.357 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.33 (0.49 to 2.17) · 2,916 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.63 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.2 (107.33 to 187.07) · 191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 250 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.7 · 484 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 839 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 1,027 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 656 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 6,822 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.08 to 0.42) · 14,300 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.06 to 0.41) · 14,490 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.43 (2.77 to 6.08) · 3,117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.38 (0 to 2.95) · 938 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.06 (0.76 to 3.36) · 2,944 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.03 (2.8 to 15.25) · 840 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.43 (3.11 to 9.75) · 899 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.34 to 3.11) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 35 cases | None | Apr 2023 – Mar 2025 |
| SSI - Colon SurgeryInfections | 0.41 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 527 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,094 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -16.6 · 443 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -11 · 961 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8 · 1,064 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 1,293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.5 to 8.7) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (6.9 to 14.9) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 310 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.8 to 17.9) · 116 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 1,600 cases | No different | Jan 2024 – Dec 2024 |
What patients said (537 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$18,305
Medicare paid this office $18,305 for 73 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 49 | $7,377 | $85 |
| Short return visit (20+ min) | 37 | $2,965 | $61 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 14 | $1,911 | $136 |
Who their Medicare patients are
73 Original Medicare patients in 2024. Average age 71 · Women 64% · Also on Medicaid 22% · Health risk score 1.17. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 60% · Chronic kidney disease 22% · Diabetes 18% · Coronary heart disease 18% · Atrial fibrillation 18% · Heart failure 15%.
The office billed $65,769, Medicare allowed $25,056 and paid $18,305; for 209 services of 24 kinds; $2,326 of it was for drugs given in the office and $15,979 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 73 | 209 | 71 | 1.17 | $65,769 | $18,305 |
| 2023 | 206 | 384 | 75 | 1.01 | $121,208 | $30,612 |
| 2022 | 347 | 959 | 75 | 0.88 | $272,483 | $80,419 |
| 2021 | 315 | 793 | 75 | 1.06 | $225,327 | $62,941 |
| 2020 | 215 | 500 | 76 | 1.05 | $125,167 | $29,323 |
| 2019 | 101 | 179 | 76 | 0.97 | $53,337 | $12,387 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 99 | $8,856 | $81 |
| Short return visit (20+ min) | 99 | $6,726 | $58 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 35 | $5,126 | $146 |
| Long return visit (40+ min) | 12 | $1,226 | $94 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $536 | $45 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $115 | $9 |
2022: 13 services
| Return visit (30+ min) | 135 | $22,617 | $109 |
| Short return visit (20+ min) | 157 | $15,649 | $73 |
| Influenza vaccine split virus, preservative free | 111 | $7,735 | $68 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 42 | $6,658 | $159 |
| Pneumococcal vaccine, 13-valent | 22 | $5,582 | $254 |
| Administration of influenza virus vaccine | 114 | $4,322 | $37 |
| Telephone medical discussion with physician, 11-20 minutes | 42 | $4,022 | $74 |
| Telephone medical discussion with physician, 21-30 minutes | 23 | $3,143 | $108 |
| New patient visit (45+ min) | 11 | $1,554 | $141 |
| New patient visit (30+ min) | 16 | $1,497 | $94 |
| Administration of pneumococcal vaccine | 31 | $1,161 | $37 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 11 | $781 | $49 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 20 | $265 | $13 |
2021: 12 services
| Short return visit (20+ min) | 134 | $17,549 | $84 |
| Return visit (30+ min) | 86 | $13,859 | $118 |
| Telephone medical discussion with physician, 11-20 minutes | 51 | $5,614 | $77 |
| Influenza vaccine split virus, preservative free | 86 | $5,612 | $65 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 32 | $5,236 | $164 |
| Telephone medical discussion with physician, 21-30 minutes | 24 | $3,905 | $122 |
| Pneumococcal vaccine, 23-valent | 17 | $2,129 | $125 |
| New patient visit (45+ min) | 15 | $2,024 | $135 |
| Administration of influenza virus vaccine | 88 | $1,930 | $22 |
| New patient visit (30+ min) | 14 | $1,286 | $92 |
| Administration of pneumococcal vaccine | 17 | $371 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $264 | $13 |
2020: 11 services
| Short return visit (20+ min) | 97 | $8,470 | $64 |
| Return visit (30+ min) | 59 | $4,391 | $65 |
| Telephone medical discussion with physician, 5-10 minutes | 52 | $3,190 | $43 |
| Pneumococcal vaccine, 23-valent | 19 | $2,247 | $118 |
| Influenza vaccine split virus, preservative free | 31 | $1,878 | $61 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 12 | $1,699 | $142 |
| New patient visit (30+ min) | 21 | $1,555 | $74 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $1,526 | $66 |
| Administration of influenza virus vaccine | 32 | $669 | $21 |
| Administration of pneumococcal vaccine | 21 | $437 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $186 | $12 |
2019: 4 services
| Return visit (30+ min) | 56 | $5,807 | $100 |
| Short return visit (20+ min) | 31 | $2,750 | $71 |
| Influenza vaccine split virus, preservative free | 19 | $1,043 | $55 |
| Administration of influenza virus vaccine | 19 | $390 | $21 |
Drugs they prescribed that Part D paid
$164,132
Pharmacies billed $164,132 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 5% of their Part D prescriptions (83 of 1,625) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%. Long-acting opioids: 27% of their opioid prescriptions.
1,391 generic and 214 brand-name prescriptions · $164,132 in drug cost · 61 antibiotic prescriptions to 41 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 18 | $26,095 | $1,450 |
| Eliquis | 13 | $14,563 | $1,120 |
| Tramadol Hcl Er | 12 | $1,513 | $126 |
| Albuterol Sulfate Hfa | 37 | $1,317 | $36 |
| Gabapentin | 40 | $1,240 | $31 |
See all 52 drugs
| Ozempic | 18 | $26,095 | $1,450 |
| Eliquis | 13 | $14,563 | $1,120 |
| Tramadol Hcl Er | 12 | $1,513 | $126 |
| Albuterol Sulfate Hfa | 37 | $1,317 | $36 |
| Gabapentin | 40 | $1,240 | $31 |
| Fluticasone-Salmeterol | 12 | $1,120 | $93 |
| Levothyroxine | 67 | $1,098 | $16 |
| Lidocaine | 11 | $869 | $79 |
| Ventolin Hfa | 11 | $805 | $73 |
| Atorvastatin | 61 | $660 | $11 |
| Losartan | 56 | $595 | $11 |
| Omeprazole | 22 | $554 | $25 |
| Fluticasone Propionate | 25 | $513 | $21 |
| Metoprolol | 22 | $483 | $22 |
| Valsartan | 11 | $434 | $39 |
| Oxycodone-Acetaminophen | 11 | $412 | $37 |
| Famotidine | 20 | $411 | $21 |
| Amlodipine Besylate-Benazepril | 11 | $399 | $36 |
| Amlodipine Besylate | 50 | $360 | $7 |
| Bupropion Xl | 14 | $353 | $25 |
| Diclofenac | 13 | $346 | $27 |
| Metoprolol | 24 | $338 | $14 |
| Rosuvastatin | 16 | $275 | $17 |
| Latanoprost | 12 | $274 | $23 |
| Hydrocodone-Acetaminophen | 29 | $271 | $9 |
| Potassium Chloride | 15 | $263 | $18 |
| Mirtazapine | 16 | $259 | $16 |
| Alendronate | 15 | $239 | $16 |
| Sumatriptan | 17 | $230 | $14 |
| Ibuprofen | 29 | $208 | $7 |
| Trazodone | 16 | $201 | $13 |
| Metformin | 13 | $201 | $15 |
| Chlorthalidone | 11 | $197 | $18 |
| Montelukast | 16 | $179 | $11 |
| Tramadol | 21 | $171 | $8 |
| Carvedilol | 16 | $159 | $10 |
| Pantoprazole | 16 | $155 | $10 |
| Triamcinolone Acetonide | 13 | $138 | $11 |
| Ciprofloxacin | 16 | $128 | $8 |
| Zolpidem | 11 | $126 | $11 |
| Lisinopril | 25 | $123 | $5 |
| Sertraline | 18 | $122 | $7 |
| Cyclobenzaprine | 19 | $116 | $6 |
| Hydrochlorothiazide | 21 | $111 | $5 |
| Isosorbide Mononitrate Er | 11 | $95 | $9 |
| Diazepam | 16 | $94 | $6 |
| Pravastatin | 18 | $90 | $5 |
| Furosemide | 18 | $84 | $5 |
| Azithromycin | 15 | $62 | $4 |
| Prednisone | 22 | $54 | $2 |
| Alprazolam | 12 | $18 | $1 |
| Lorazepam | 12 | $8 | $1 |
Year by year
| 2024 | 1,625 | 223 | 5% (83) | 13% | $164,132 |
| 2023 | 1,475 | 327 | 2% (25) | 10% | $114,197 |
| 2022 | 1,871 | 291 | 1% (24) | None | $146,896 |
| 2021 | 1,370 | 225 | 2% (22) | None | $89,246 |
| 2020 | 934 | 204 | 1% (13) | 14% | $67,841 |
| 2019 | 1,806 | 179 | None | 14% | $146,642 |
| 2018 | 1,669 | 82 | None | 12% | $78,356 |
| 2017 | 1,112 | 77 | None | 12% | $41,081 |
| 2016 | 738 | 51 | 2% (18) | 15% | $24,422 |
| 2015 | 350 | 40 | 6% (21) | None | $11,651 |
| 2014 | 211 | 47 | 7% (14) | None | $4,709 |
| 2013 | 248 | 47 | 9% (21) | None | $11,152 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 36 drugs
| Eliquis | 11 | $12,519 | $1,138 |
| Gabapentin | 42 | $1,652 | $39 |
| Levothyroxine | 79 | $1,072 | $14 |
| Valsartan-Hydrochlorothiazide | 11 | $814 | $74 |
| Albuterol Sulfate Hfa | 24 | $813 | $34 |
| Atorvastatin | 68 | $651 | $10 |
| Losartan | 40 | $574 | $14 |
| Metoprolol | 28 | $543 | $19 |
| Amlodipine Besylate | 59 | $421 | $7 |
| Diclofenac | 11 | $381 | $35 |
| Simvastatin | 41 | $365 | $9 |
| Losartan-Hydrochlorothiazide | 13 | $354 | $27 |
| Fluticasone Propionate | 16 | $343 | $21 |
| Allopurinol | 14 | $331 | $24 |
| Potassium Chloride | 11 | $318 | $29 |
| Metformin | 24 | $288 | $12 |
| Lisinopril | 45 | $273 | $6 |
| Pravastatin | 13 | $257 | $20 |
| Omeprazole | 15 | $248 | $17 |
| Cyclobenzaprine | 14 | $229 | $16 |
| Trazodone | 15 | $188 | $13 |
| Hydrochlorothiazide | 38 | $187 | $5 |
| Metoprolol | 19 | $175 | $9 |
| Donepezil | 11 | $174 | $16 |
| Furosemide | 21 | $146 | $7 |
| Pantoprazole | 11 | $140 | $13 |
| Alendronate | 17 | $140 | $8 |
| Triamcinolone Acetonide | 13 | $118 | $9 |
| Ibuprofen | 12 | $105 | $9 |
| Zolpidem | 14 | $103 | $7 |
| Citalopram Hbr | 14 | $96 | $7 |
| Sertraline | 11 | $74 | $7 |
| Azithromycin | 13 | $67 | $5 |
| Prednisone | 18 | $55 | $3 |
| Amoxicillin | 11 | $42 | $4 |
| Sildenafil Citrate | 13 | $41 | $3 |
2022: 50 drugs
| Eliquis | 14 | $17,171 | $1,227 |
| Januvia | 13 | $17,028 | $1,310 |
| Climara Pro | 11 | $2,491 | $226 |
| Levothyroxine | 100 | $1,818 | $18 |
| Synthroid | 13 | $1,288 | $99 |
| Gabapentin | 29 | $1,238 | $43 |
| Atorvastatin | 98 | $1,235 | $13 |
| Metoprolol | 39 | $992 | $25 |
| Albuterol Sulfate Hfa | 26 | $928 | $36 |
| Rosuvastatin | 11 | $818 | $74 |
| Oxybutynin Chloride Er | 15 | $694 | $46 |
| Losartan | 49 | $681 | $14 |
| Amlodipine Besylate | 76 | $611 | $8 |
| Omeprazole | 33 | $515 | $16 |
| Losartan-Hydrochlorothiazide | 26 | $480 | $18 |
| Allopurinol | 13 | $465 | $36 |
| Lisinopril | 70 | $444 | $6 |
| Trazodone | 33 | $440 | $13 |
| Nitrofurantoin Mono-Macro | 19 | $433 | $23 |
| Chlorthalidone | 21 | $409 | $19 |
| Nystatin | 11 | $372 | $34 |
| Venlafaxine Hcl Er | 14 | $328 | $23 |
| Hydrochlorothiazide | 65 | $326 | $5 |
| Escitalopram | 18 | $322 | $18 |
| Potassium Chloride | 18 | $318 | $18 |
| Alendronate | 41 | $315 | $8 |
| Isosorbide Mononitrate Er | 15 | $313 | $21 |
| Sertraline | 18 | $298 | $17 |
| Simvastatin | 48 | $293 | $6 |
| Metformin | 21 | $291 | $14 |
| Pravastatin | 15 | $281 | $19 |
| Donepezil | 18 | $280 | $16 |
| Fluoxetine | 11 | $274 | $25 |
| Tamsulosin | 17 | $249 | $15 |
| Pantoprazole | 17 | $243 | $14 |
| Cyclobenzaprine | 22 | $230 | $10 |
| Warfarin | 22 | $225 | $10 |
| Zolpidem Tartrate Er | 12 | $219 | $18 |
| Lovastatin | 15 | $202 | $13 |
| Hydralazine | 12 | $186 | $15 |
| Citalopram Hbr | 18 | $167 | $9 |
| Furosemide | 22 | $163 | $7 |
| Fluticasone Propionate | 19 | $161 | $8 |
| Triamcinolone Acetonide | 21 | $147 | $7 |
| Mirtazapine | 14 | $130 | $9 |
| Ciprofloxacin | 18 | $127 | $7 |
| Cephalexin | 13 | $112 | $9 |
| Prednisone | 28 | $76 | $3 |
| Azithromycin | 12 | $70 | $6 |
| Amoxicillin | 15 | $63 | $4 |
2021: 36 drugs
| Lantus Solostar | 11 | $3,734 | $339 |
| Levothyroxine | 77 | $1,904 | $25 |
| Albuterol Sulfate Hfa | 38 | $1,365 | $36 |
| Metoprolol | 48 | $1,221 | $25 |
| Gabapentin | 37 | $1,160 | $31 |
| Atorvastatin | 76 | $1,087 | $14 |
| Rosuvastatin | 13 | $934 | $72 |
| Losartan | 40 | $699 | $17 |
| Amlodipine Besylate | 62 | $601 | $10 |
| Pravastatin | 12 | $422 | $35 |
| Nitrofurantoin Mono-Macro | 16 | $302 | $19 |
| Alendronate | 32 | $294 | $9 |
| Chlorthalidone | 11 | $289 | $26 |
| Omeprazole | 19 | $284 | $15 |
| Trazodone | 20 | $269 | $13 |
| Escitalopram | 16 | $269 | $17 |
| Losartan-Hydrochlorothiazide | 16 | $263 | $16 |
| Lorazepam | 17 | $262 | $15 |
| Pantoprazole | 11 | $260 | $24 |
| Hydrochlorothiazide | 49 | $253 | $5 |
| Lisinopril | 33 | $241 | $7 |
| Tamsulosin | 12 | $232 | $19 |
| Diclofenac | 12 | $215 | $18 |
| Metformin | 18 | $213 | $12 |
| Hydrocodone-Acetaminophen | 11 | $191 | $17 |
| Cyclobenzaprine | 14 | $183 | $13 |
| Ciprofloxacin | 25 | $156 | $6 |
| Furosemide | 23 | $145 | $6 |
| Fluticasone Propionate | 12 | $132 | $11 |
| Prednisone | 27 | $131 | $5 |
| Clindamycin | 12 | $102 | $9 |
| Simvastatin | 18 | $99 | $5 |
| Fluoxetine | 12 | $98 | $8 |
| Triamcinolone Acetonide | 11 | $80 | $7 |
| Lisinopril-Hydrochlorothiazide | 13 | $79 | $6 |
| Citalopram Hbr | 11 | $16 | $1 |
2020: 27 drugs
| Januvia | 14 | $14,163 | $1,012 |
| Xarelto | 13 | $7,308 | $562 |
| Rosuvastatin | 11 | $912 | $83 |
| Albuterol Sulfate Hfa | 18 | $786 | $44 |
| Levothyroxine | 29 | $766 | $26 |
| Atorvastatin | 37 | $457 | $12 |
| Losartan | 29 | $426 | $15 |
| Nitrofurantoin Mono-Macro | 13 | $282 | $22 |
| Fluticasone Propionate | 20 | $275 | $14 |
| Metformin | 27 | $259 | $10 |
| Tamsulosin | 19 | $223 | $12 |
| Hydrochlorothiazide | 36 | $222 | $6 |
| Amlodipine Besylate | 35 | $216 | $6 |
| Alendronate | 16 | $206 | $13 |
| Gabapentin | 12 | $198 | $16 |
| Diclofenac | 11 | $163 | $15 |
| Metoprolol | 14 | $160 | $11 |
| Lisinopril | 20 | $154 | $8 |
| Pantoprazole | 14 | $139 | $10 |
| Finasteride | 15 | $130 | $9 |
| Ibuprofen | 16 | $125 | $8 |
| Clindamycin | 13 | $110 | $8 |
| Simvastatin | 17 | $108 | $6 |
| Escitalopram | 11 | $100 | $9 |
| Ciprofloxacin | 17 | $90 | $5 |
| Cyclobenzaprine | 12 | $81 | $7 |
| Sertraline | 12 | $51 | $4 |
2019: 48 drugs
| Januvia | 13 | $11,843 | $911 |
| Symbicort | 18 | $6,443 | $358 |
| Olopatadine | 14 | $2,733 | $195 |
| Ventolin Hfa | 36 | $2,142 | $60 |
| Albuterol Sulfate Hfa | 35 | $1,595 | $46 |
| Comfort Ez Pen Needle | 12 | $1,484 | $124 |
| Alcohol Prep Pads | 23 | $1,035 | $45 |
| Oxybutynin Chloride | 34 | $965 | $28 |
| Proair Hfa | 14 | $912 | $65 |
| Duloxetine | 13 | $741 | $57 |
| Chlorthalidone | 32 | $686 | $21 |
| Atorvastatin | 61 | $670 | $11 |
| Amlodipine Besylate | 126 | $549 | $4 |
| Pravastatin | 24 | $539 | $22 |
| Gabapentin | 23 | $464 | $20 |
| Omeprazole | 29 | $460 | $16 |
| Fluticasone Propionate | 36 | $457 | $13 |
| Ammonium Lactate | 12 | $444 | $37 |
| Metformin | 85 | $399 | $5 |
| Cyclobenzaprine | 43 | $389 | $9 |
| Levothyroxine | 32 | $387 | $12 |
| Losartan | 32 | $302 | $9 |
| Simvastatin | 65 | $289 | $4 |
| Lisinopril | 80 | $277 | $3 |
| Meclizine | 21 | $277 | $13 |
| Nifedipine Er | 11 | $219 | $20 |
| Montelukast | 21 | $202 | $10 |
| Hydrochlorothiazide | 60 | $201 | $3 |
| Ranitidine | 29 | $179 | $6 |
| Ibuprofen | 21 | $179 | $9 |
| Diclofenac | 12 | $176 | $15 |
| Allopurinol | 18 | $165 | $9 |
| Latanoprost | 15 | $152 | $10 |
| Hydralazine | 15 | $148 | $10 |
| Pantoprazole | 19 | $141 | $7 |
| Metoprolol | 29 | $133 | $5 |
| Lisinopril-Hydrochlorothiazide | 23 | $130 | $6 |
| Carvedilol | 29 | $123 | $4 |
| Glipizide Er | 17 | $121 | $7 |
| Naproxen | 13 | $112 | $9 |
| Hydrocortisone | 24 | $103 | $4 |
| Venlafaxine Hcl Er | 13 | $92 | $7 |
| Triamcinolone Acetonide | 14 | $80 | $6 |
| Isosorbide Mononitrate Er | 11 | $76 | $7 |
| Ciprofloxacin | 14 | $71 | $5 |
| Prednisone | 14 | $61 | $4 |
| Clopidogrel | 14 | $52 | $4 |
| Furosemide | 17 | $46 | $3 |
2018: 39 drugs
| Januvia | 13 | $7,264 | $559 |
| Symbicort | 25 | $6,539 | $262 |
| Levemir Flextouch | 12 | $6,444 | $537 |
| Basaglar Kwikpen U-100 | 11 | $3,552 | $323 |
| Ventolin Hfa | 31 | $1,695 | $55 |
| Olopatadine | 14 | $1,404 | $100 |
| Gabapentin | 47 | $886 | $19 |
| Alcohol Prep Pads | 17 | $867 | $51 |
| Chlorthalidone | 27 | $758 | $28 |
| Omeprazole | 52 | $753 | $14 |
| Proair Hfa | 12 | $725 | $60 |
| Alcohol Pads | 15 | $667 | $44 |
| Atorvastatin | 48 | $639 | $13 |
| Amlodipine Besylate | 106 | $544 | $5 |
| Rosuvastatin | 24 | $542 | $23 |
| Oxybutynin Chloride | 33 | $518 | $16 |
| Pravastatin | 30 | $444 | $15 |
| Levothyroxine | 28 | $373 | $13 |
| Metformin | 91 | $372 | $4 |
| Simvastatin | 66 | $322 | $5 |
| Ranitidine | 47 | $309 | $7 |
| Lisinopril | 82 | $302 | $4 |
| Carvedilol | 33 | $290 | $9 |
| Fluticasone Propionate | 23 | $278 | $12 |
| Losartan | 48 | $255 | $5 |
| Cyclobenzaprine | 24 | $225 | $9 |
| Metoprolol | 40 | $189 | $5 |
| Lisinopril-Hydrochlorothiazide | 42 | $139 | $3 |
| Ibuprofen | 21 | $123 | $6 |
| Montelukast | 23 | $122 | $5 |
| Clopidogrel | 27 | $119 | $4 |
| Hydrochlorothiazide | 41 | $114 | $3 |
| Acyclovir | 12 | $108 | $9 |
| Meclizine | 13 | $100 | $8 |
| Losartan-Hydrochlorothiazide | 18 | $83 | $5 |
| Furosemide | 23 | $82 | $4 |
| Naproxen | 11 | $75 | $7 |
| Hydrocortisone | 11 | $52 | $5 |
| Famotidine | 12 | $41 | $3 |
2017: 29 drugs
| Januvia | 14 | $5,592 | $399 |
| Symbicort | 20 | $4,953 | $248 |
| Humalog | 11 | $3,208 | $292 |
| Ventolin Hfa | 19 | $1,014 | $53 |
| Alcohol Prep Pads | 17 | $764 | $45 |
| Rosuvastatin | 12 | $467 | $39 |
| Oxybutynin Chloride | 17 | $463 | $27 |
| Lisinopril | 95 | $299 | $3 |
| Ibuprofen | 45 | $292 | $6 |
| Hydralazine | 16 | $273 | $17 |
| Montelukast | 31 | $241 | $8 |
| Levothyroxine | 22 | $237 | $11 |
| Atorvastatin | 28 | $204 | $7 |
| Pravastatin | 17 | $202 | $12 |
| Gabapentin | 12 | $166 | $14 |
| Metformin | 56 | $162 | $3 |
| Amlodipine Besylate | 50 | $161 | $3 |
| Ranitidine | 23 | $155 | $7 |
| Simvastatin | 43 | $144 | $3 |
| Omeprazole | 27 | $135 | $5 |
| Hydrochlorothiazide | 36 | $133 | $4 |
| Lisinopril-Hydrochlorothiazide | 33 | $131 | $4 |
| Losartan | 23 | $125 | $5 |
| Carvedilol | 15 | $113 | $8 |
| Acyclovir | 12 | $108 | $9 |
| Cyclobenzaprine | 12 | $89 | $7 |
| Losartan-Hydrochlorothiazide | 16 | $64 | $4 |
| Clopidogrel | 13 | $51 | $4 |
| Metoprolol | 14 | $43 | $3 |
2016: 22 drugs
| Januvia | 16 | $5,977 | $374 |
| Ventolin Hfa | 12 | $626 | $52 |
| Proair Respiclick | 12 | $602 | $50 |
| Hydrocodone-Acetaminophen | 14 | $314 | $22 |
| Fluticasone Propionate | 23 | $252 | $11 |
| Lisinopril | 65 | $250 | $4 |
| Levothyroxine | 18 | $211 | $12 |
| Acyclovir | 14 | $210 | $15 |
| Ranitidine | 25 | $182 | $7 |
| Hydralazine | 11 | $159 | $14 |
| Metoprolol | 11 | $138 | $13 |
| Simvastatin | 37 | $137 | $4 |
| Ibuprofen | 23 | $130 | $6 |
| Montelukast | 12 | $127 | $11 |
| Hydrochlorothiazide | 20 | $118 | $6 |
| Omeprazole | 24 | $109 | $5 |
| Amlodipine Besylate | 41 | $105 | $3 |
| Losartan-Hydrochlorothiazide | 18 | $87 | $5 |
| Atorvastatin | 14 | $80 | $6 |
| Carvedilol | 11 | $67 | $6 |
| Metformin | 22 | $59 | $3 |
| Lisinopril-Hydrochlorothiazide | 16 | $55 | $3 |
2015: 9 drugs
| Proair Hfa | 20 | $1,026 | $51 |
| Hydrocodone-Acetaminophen | 16 | $601 | $38 |
| Amlodipine Besylate | 20 | $172 | $9 |
| Levothyroxine | 14 | $170 | $12 |
| Lisinopril | 20 | $114 | $6 |
| Simvastatin | 13 | $113 | $9 |
| Hydrochlorothiazide | 15 | $95 | $6 |
| Ibuprofen | 13 | $74 | $6 |
| Ranitidine | 14 | $65 | $5 |
2014: 2 drugs
| Omeprazole | 13 | $201 | $15 |
| Warfarin | 11 | $120 | $11 |
2013: 2 drugs
| Proair Hfa | 11 | $560 | $51 |
| Warfarin | 16 | $208 | $13 |
Money from drug and device companies
$13 in 2019
A payment is not proof that care is biased.
| Pfizer | Lyrica | $13 | 1 payment
|
See the published payment
| Pfizer | Meals · 2019-03-18 | Lyrica | $13 |
Professional record
- NPI
- 1679860142
- Licence
- CA C159091, MI 4301098534California C159091: Current · expires 2028-10-31
- Trained
- Wayne State University School of Medicine, 2011 · 15 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 6475 Camden Ave Ste 105, San Jose, CA, 95120
- NPI first listed
- 2011-07-06
- NPI last updated
- 2019-08-08
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 18917 Joy Rd, Detroit, MI, 48228 · 24911 Little Mack Ave, Saint Clair Shores, MI, 48080